Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LABCAT TCJUSS in Depressive Episode
NCT02532660Phase 3Terminated
- Sponsor
- Catarinense Pharma
- Start
- Jul 2018
- Primary completion
- Jun 2022
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 3 trial of trichilia catigua in major depressive disorder (MDD), sponsored by Catarinense Pharma. Started Jul 2018; status: terminated.
02
Drugs
trichilia catigua
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02532660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532660.